Patent details

Basic Information

Publication number:

EP1255537

PCT Application Number:

PCT/EP/2001/001032

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019057173

PCT Publication Number:

WO/2001/056552

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER

French Title of Invention:

INHIBITEURS DE LA FARNESYL PROTEINE TRANSFERASE POUR LE TRAITEMENT DU CANCER DU SEIN

German Title of Invention:

FARNESYL PROTEIN TRANSFERASE INHIBITOREN ZUR BEHANDLUNG VON BRUSTKREBS

SPC Number:

Dates

Filing date:

01/02/2001

Grant date:

19/04/2006

EP Publication Date:

19/04/2006

PCT Publication Date:

09/08/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/11/2002

EP B1 Publication Date:

19/04/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/02/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/02/2001

 

 

Name:

JANSSEN PHARMACEUTICA N.V.

Address:

Turnhoutsebaan 30, 2340 Beerse, Belgium (BE)

Agent

Name:

VAN MALDEREN MICHEL

From:

15/06/2006

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PALMER Peter Albert, Janssen Pharmaceutica N.V

Address:

Belgium (BE)

2

Name:

HORAK Ivan, David

Address:

United States (US)

Priority

Priority Number:

00200373

Priority Date:

04/02/2000

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/01/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages